ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Activity

76 hedge funds and large institutions have $631M invested in Adaptimmune Therapeutics in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 12 closing their positions.

Holders
76
Holders Change
+5
Holders Change %
+7.04%
% of All Funds
1.74%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
17
Increased
26
Reduced
19
Closed
12
Calls
$721K
Puts
$983K
Net Calls
-$262K
Net Calls Change
-$312K

Top Buyers

1
MCMC
1
Matrix Capital Management Company
New Hampshire
$156M
2
NMC
2
NEA Management Company
Maryland
$150M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$16.9M
4
Millennium Management
4
Millennium Management
New York
$16.6M
5
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$28.8M

Top Sellers

1
O
1
OrbiMed
New York
$9.73M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$43M
3
AG
3
Artal Group
Luxembourg
$0
4
GAMA
4
Graticule Asia Macro Advisors
New York
$4.68M
5
Axa
5
Axa
France
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MCMC
1
Matrix Capital Management Company
New Hampshire
$156M 13,882,011 +1,668,500 +14%
NMC
2
NEA Management Company
Maryland
$150M 13,332,611 +1,306,612 +11%
Capital World Investors
3
Capital World Investors
California
$76.3M 6,792,700 – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$43M 3,827,467 -803,792 -17%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$28.8M 2,565,409 +644,816 +34%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$16.9M 1,507,965 +906,087 +151%
Millennium Management
7
Millennium Management
New York
$16.6M 1,477,641 +672,046 +83%
OIM
8
Oracle Investment Management
Connecticut
$14.9M 1,330,070 +297,349 +29%
Renaissance Technologies
9
Renaissance Technologies
New York
$14.7M 1,306,000 +312,000 +31%
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$10.6M 947,068 +224,078 +31%
RSCM
11
Rock Springs Capital Management
Maryland
$9.83M 875,000 – –
O
12
OrbiMed
New York
$9.73M 866,593 -1,048,067 -55%
TCM
13
Tekla Capital Management
Massachusetts
$9.61M 855,468 -79,900 -9%
BlackRock
14
BlackRock
New York
$9.06M 806,952 +19,765 +3%
QF
15
QVT Financial
New York
$7.84M 731,510 -122,375 -14%
Fidelity International
16
Fidelity International
Bermuda
$7.49M 666,891 – –
GAMA
17
Graticule Asia Macro Advisors
New York
$4.68M 416,457 -232,188 -36%
FCMI
18
Foresite Capital Management II
California
$4.49M 400,000 +400,000 New
EIM
19
Essex Investment Management
Massachusetts
$4.2M 374,017 +286,710 +328%
Deutsche Bank
20
Deutsche Bank
Germany
$3.77M 335,886 +160,940 +92%
VIA
21
Vident Investment Advisory
Georgia
$2.87M 231,349 +61,943 +37%
A
22
Abingworth
United Kingdom
$2.81M 250,000 – –
RG
23
Rathbones Group
United Kingdom
$2.73M 243,430 -69,500 -22%
Ameriprise
24
Ameriprise
Minnesota
$2.49M 221,987 +221,987 New
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$2.09M 185,660 +164,704 +786%
1
2 3 4